Robert I. Blum - Mar 2, 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
President & CEO, Director
Signature
By: Robert Wong For: Robert I.Blum
Stock symbol
CYTK
Transactions as of
Mar 2, 2022
Transactions value $
$6,176,362
Form type
4
Date filed
3/3/2022, 03:39 PM
Previous filing
Mar 1, 2022
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Tax liability -$597K -15.9K -4.36% $37.63 348K Mar 2, 2022 Direct F1
transaction CYTK Common Stock Award $0 +85K +24.43% $0.00 433K Mar 2, 2022 Direct F2
holding CYTK Common Stock 2.08K Mar 2, 2022 by Trust 1 F3
holding CYTK Common Stock 2.08K Mar 2, 2022 by Trust 2 F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (right to buy) Award $100K +2.66K $37.63 2.66K Mar 2, 2022 Common Stock 2.66K $37.63 Direct F5
transaction CYTK Non-Qualified Stock Option (right to buy) Award $6.67M +177K $37.63 177K Mar 2, 2022 Common Stock 177K $37.63 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person.
F2 Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.
F3 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F4 Shares held by The Brittany Blum 2003 Irrevocable Trust.
F5 This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.